Sattva Sukun Lifecare Ltd

Change details

• Old name: Sattva Sukun Lifecare Limited; New name: Tavexia Lifecare Limited.
• Effect date: 14 August 2026.
• Approvals: MCA approved name change; BSE approved the name change.
• CIN unchanged: L51219MH1980PLC329224.
• Two-year display requirement: old name to be shown with new name; no change to rights/liabilities.
• Fresh Certificate of Incorporation issued by ROC CPC evidences change of name.

Key Decisions

• Board approved corrigendum to EOGM notice on name change to Tavexia Lifecare Limited.
• EOGM scheduled for 22 July 2026 at 2:00 PM via video conference to consider name change.
• Special Resolution proposed to change name from Sattva Sukun Lifecare Limited to Tavexia Lifecare Limited.
• MOA and AOA to be amended to reflect the new company name.
• Name Clause to be amended to 'Tavexia Lifecare Limited'.
• Board authorized Directors and Company Secretary to execute documents and take steps to effect change.
• CA certificate under Regulation 45(1) SEBI LODR confirming compliance to be available for inspection.

Dematerialisation status

• Dematerialisation requests received during the reporting period were processed and confirmed to depositories.
• Securities dematerialised have been listed on stock exchanges where earlier issues are listed.
• Physical certificates for dematerialisation were mutilated and cancelled after verification, and the depository's name substituted as registered owner.

Director appointment

• Special resolution to regularise Sachin B. Manseta as Non-Executive Independent Director for five-year term commencing 22 July 2026.
• Subject to shareholder confirmation within 3 months from appointment.

MOA main object changes

• Special resolution to alter Clause III(A) to insert main objects 6–8.
• Objects include pharma chemicals, CRO/CDMO, R&D centers, IP rights, and alliances.
• Board/Director authorization to file necessary forms to give effect.

Name change

• Special resolution to change company name to Tavexia Lifecare Limited or Trumaxa Lifecare Limited (or other approved name).
• CA certificate confirms compliance; change subject to regulatory approval.

Voting status

• Voting outcome not disclosed in filing; results to be announced after EGM.

Shareholding/governance impact

• No direct impact on promoter holdings; MOA/name changes affect governance/branding only.
• New objects may enable broader business activities.

Director appointments

• Regularize Sachin Bhanubhai Manseta as Non-Executive Independent Director for 5 years from 22 July 2026.
• Regularize Chirag Dedhia as Non-Executive Non-Independent Director for 5 years from 22 July 2026.

Name change and MOA changes

• Change of name to Tavexia Lifecare Limited or alternatives, subject to CRC and members’ approval.
• Alter MOA main object to include pharma trading and CRO/CDMO/CRAMS services.

EOGM and governance actions

• Notice of Extra-Ordinary General Meeting to be held via video-conferencing.
• Brajesh Gupta appointed Scrutinizer for E-voting.
• MD/ED/CS authorized to issue EOGM notice and oversee E-voting.

Registered office shift

• Registered office shifted within Mumbai, effective 1 July 2026.

Director appointments

• Sachin Manseta appointed Non-Executive Independent Director; term five years from 22 July 2026, subject to member approval.
• Chirag Dedhia appointed Non-Executive Non-Independent Director; five-year term from 22 July 2026, subject to member approval.

Name change proposal

• Proposed name change to Tavexia Lifecare Limited or CRC-approved alternative.
• Change contingent on CRC/MCA approvals and General Meeting approval.

MOA amendments

• Alteration of MOA Main Object Clause; pending shareholder and regulatory approvals.

EOGM and governance

• Notice for Extra-Ordinary General Meeting to be conducted via video conferencing.

Scrutinizer appointment

• Brajesh Gupta appointed Scrutinizer for EOGM e-voting.

Notice dispatch authorization

• MD/ED/Company Secretary authorized to issue EOGM notice and manage e-voting.

Board appointments

• Mr. Sachin Bhanubhai Manseta appointed Additional Non-Executive Independent Director, effective 24 April 2026, subject to member approval.
• He has secretarial and legal advisory experience and is not related to any KMP, director, or promoter.
• Mr. Chirag Dedhia appointed Additional Non-Executive Non-Independent Director, effective 24 April 2026, subject to member approval.
• He holds a Master’s in Finance from the University of Surrey and a B.Com from Mithibai College.
• He is not related to any KMP, director, or promoter.
• Both appointees were confirmed not debarred from holding directorship by SEBI or any authority.